AKAN
Akanda Corp. Common Shares
Medicinal Chemicals & Botanical Products
Best Pharmaceutical Stocks 2026 →
Akanda Corp. Common Shares (AKAN) Stock: Buy, Sell, or Hold?
$0.71
-0.03 (-3.66%)
βΌ
5d:
-16.98%
30d:
-46.82%
90d:
-89.03%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (47%)
Quality Score
40/100
Position
OVERSOLD
30-Day Fair Range
$0.84 β $1.56
Position: OVERSOLD
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.72 / $1.15
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
βΈοΈ WAIT FOR STABILIZATION: AKAN is down 17.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When AKAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: AKAN is currently trading at $0.71, which is considered oversold relative to its 30-day fair value range of $0.84 to $1.56.
Technical Outlook: Technically, AKAN is in a strong downtrend. The price is currently testing key support at $0.72. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: AKAN scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AKAN is in a strong downtrend. The price is currently testing key support at $0.72. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: AKAN scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.84 -
$1.56
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
Trading Range & Key Levels
30-Day Trading Range
$0.84 -
$1.56
Current vs Trading Range
OVERSOLD
Support Level
$0.72
Resistance Level
$1.15
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- WARNING: Composite score 40/100 in the bottom quintile β this cohort historically lags the market
Fundamental Context
Revenue Growth (YoY)
21.9%
Share AKAN Analysis
Share this live AKAN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AKAN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate a bullish sentiment towards the microcap stock FMFC (symbol for $AKAN), with traders expecting it to experience parabolic pre-market runs based on its low float status.
Key Retail Themes:
Low float stocks
Parabolic price movements
Pre-market run
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:13 PM ET
Data refreshes hourly during market hours. Next update: 2:13 PM
Data refreshes hourly during market hours. Next update: 2:13 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I⦠|
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I⦠|
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
TEVA
Teva Pharma Industries L⦠|
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AKAN Research Pages